Authors
Loading...
Randomized trial reveals the glucocorticoid-fas pathway's role in immune evasion in metastatic tumor cells, suggesting new treatment strategies.
Agudo et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: